Search research articles
Contact Us
Filters
Showing results (531-540 of 571) with videos related to
Page
of 58
Sort By:
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
Nature Immunology
|
September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2023
Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response
Jonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
October 4, 2023
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
Steven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Nature Immunology
|
March 20, 2024
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.
Nature
|
December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Neuro-Oncology
|
June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Rishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
Page
of 58
Search research articles
Search
Showing results (531-540 of 571) with videos related to
Sort By:
Page
of 58
Nature Communications
|
June 24, 2026
Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance
Samuel J Wright, Izabella Zamora, Milan Parikh, et al.
Nature Communications
|
October 27, 2017
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Moshe Sade-Feldman, Yunxin J Jiao, Jonathan H Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy
Xue Bai, Jiani Hu, Allison Betof Warner, et al.
Nature Immunology
|
September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer
Juan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2023
Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response
Jonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.
Nature
|
September 28, 2017
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
October 4, 2023
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor
Steven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Nature Immunology
|
March 20, 2024
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan H Chen, Linda T Nieman, Maxwell Spurrell, et al.
Nature
|
December 12, 2018
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas
Hezhe Lu, Shujing Liu, Gao Zhang, et al.
Neuro-Oncology
|
June 28, 2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Rishab Ramapriyan, Fred G Barker, Leland G Richardson, et al.
Page
of 58